Dianthus Therapeutics (DNTH) Operating Margin (2022 - 2025)
Dianthus Therapeutics' quarterly Operating Margin came in at 10173.74% in Q3 2025, down 879713.0% year-on-year from N/an in Q3 2024, and up 43.78% quarter-over-quarter from 18096.89% in Q2 2025.
Dianthus Therapeutics has reported Operating Margin for 4 years, with the latest figure at 10173.74% in Q3 2025.
- For the quarter ending Q3 2025, Operating Margin fell 879713.0% year-over-year to 10173.74%; the trailing twelve-month figure through Sep 2025 stood at 4504.27% (down 295031.0% YoY), and the FY2024 full-year result was 1633.74%, up 7093.0% from the prior year.
- Operating Margin for Q3 2025 stood at 10173.74%, up from 18096.89% in the prior quarter.
- The five-year high for Operating Margin was 703.67% in Q3 2022, with the low at 18096.89% in Q2 2025.
- Average Operating Margin over 4 years is 3635.65%, with a median of 1751.0% recorded in 2023.
- Year-over-year, Operating Margin soared 63438 bps in 2024 and tumbled 1690505 bps in 2025.
- Tracing DNTH's Operating Margin over 4 years: stood at 923.4% in 2022, then sank by 229 bps to 3041.31% in 2023, then rose by 21 bps to 2406.94% in 2024, then slumped by 323 bps to 10173.74% in 2025.
- The last three Operating Margin figures came in at 10173.74% (Q3 2025), 18096.89% (Q2 2025), and 2764.75% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10,173.74% |
| Jun 30, 2025 | -18,096.89% |
| Mar 31, 2025 | -2,764.75% |
| Dec 31, 2024 | -2,406.94% |
| Sep 30, 2024 | -1,376.61% |
| Jun 30, 2024 | -1,191.84% |
| Mar 31, 2024 | -2,041.65% |
| Dec 31, 2023 | -3,041.31% |
| Sep 30, 2023 | -1,751.00% |
| Jun 30, 2023 | -1,177.60% |
| Mar 31, 2023 | -1,614.08% |
| Dec 31, 2022 | -923.40% |
| Sep 30, 2022 | -703.67% |